Lv1
18 积分 2022-09-06 加入
225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
2天前
已完结
Optimizing treatment for metastatic castration‐resistant prostate cancer: Food and Drug Administration‐approved therapies, emerging strategies, and biomarker‐driven approaches
2天前
已完结
Lanthanide Luminescence for Biomedical Analyses and Imaging
6天前
已完结
Reversed-phase liquid chromatography of biologically active lipophilic chelators
7天前
已完结
Comparative evaluation of chelators in the context of analysis of antibody oxidative stability
7天前
已关闭
Macrocyclic and Hydroxamate Ligands for 225 Ac Radiopharmaceuticals: Evaluating SSTR2-Targeting Potential
9天前
已完结
[225Ac]Ac–anti-DLL3 targeted alpha therapy for neuroendocrine tumors: preclinical radiosynthesis, biodistribution, and therapeutic efficacy
9天前
已关闭
Fermentations of pectin-rich biomass with recombinant bacteria to produce fuel ethanol
15天前
已关闭
Preclinical Evaluation of [225Ac]Ac–Sibrotuzumab Employing a PEG4–Macropa Site‐Specific Chelation Strategy for Targeted Ablation of Cancer‐Associated Fibroblasts in Desmoplastic Tumors
15天前
已完结
皖公网安备34019202002308
